Edition:
United States

Brainsway Ltd (BRIN.TA)

BRIN.TA on Tel Aviv Stock Exchange

1,748.00ILa
17 Aug 2017
Change (% chg)

-16.00 (-0.91%)
Prev Close
1,764.00
Open
1,764.00
Day's High
1,784.00
Day's Low
1,748.00
Volume
15,581
Avg. Vol
40,145
52-wk High
2,177.00
52-wk Low
1,536.00

Latest Key Developments (Source: Significant Developments)

Brainsway announces positive final results of deep TMS multicenter study in OCD patients
Monday, 12 Jun 2017 12:35pm EDT 

June 12 (Reuters) - Brainsway Ltd :Brainsway® announces positive final results of its deep tms multicenter study in obsessive compulsive disorder (OCD) patients.Patients who received active treatment were significantly better than those who received sham treatment.Based on results of study, company will prepare submission to fda in order to enable brainsway to market device for indication tested.Results showed after 6 weeks of treatment, there was statistically significant improvement in YBOCS score for active treatment group versus sham.  Full Article

Brainsway reports revenue growth for third quarter in a row
Tuesday, 23 Aug 2016 09:00am EDT 

Brainsway Ltd : Brainsway reports consistent revenue growth for third quarter in a row and provides company updates . Q2 net profit was $818,000 compared with a loss of $759,000 in Q2 2015 .Q2 revenues up by 90%, reaching $2.8 million, compared to Q2 2015.  Full Article

BRIEF-Brainsway announces positive final results of deep TMS multicenter study in OCD patients

* Brainsway® announces positive final results of its deep tms multicenter study in obsessive compulsive disorder (OCD) patients

No consensus analysis data available.